ADAR1 Capital Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
ADAR1 Capital Management's FUSN Position: Q2 2024 in Review
ADAR1 Capital Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 177,200 shares — an estimated $3.78M sold.
ADAR1 Capital Management first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $3.78M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.
- ADAR1 Capital Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
- ADAR1 Capital Management sold 177,200 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $3.78M.
- ADAR1 Capital Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
- ADAR1 Capital Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $3.78M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.
Based on ADAR1 Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.